Law360, New York (November 03, 2009) -- Antitrust officials scrutinizing Danaher Corp.’s proposed acquisition of MDS Inc.’s analytical technologies unit have extended their review of the $650 million cash transaction.
On Tuesday, MDS announced that the U.S. Federal Trade Commission sent the life sciences company a second request for information about the slated deal, suggesting regulatory concerns about Danaher’s expansion...
